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Cardiovascular Surgery
Remote Ischemic Preconditioning Protects the Brain Against
Injury After Hypothermic Circulatory Arrest
Hanna A. Jensen, MD, PhD*; Stavros Loukogeorgakis, MBBS, BSc, PhD*; Fredrik Yannopoulos, BSc;
Eija Rimpila¨inen, MD; Axel Petzold, MD, PhD; Hannu Tuominen, MD, PhD; Pasi Lepola, MSc;
Raymond J. MacAllister, MD, FRCP; John E. Deanfield, MB, BChir (Cantab), FRCP;
Tuomas Ma¨kela¨, BSc; Kirsi Alestalo, BSc; Kai Kiviluoma, MD, PhD; Vesa Anttila, MD, PhD;
Victor Tsang, MS, FRCS; Tatu Juvonen, MD, PhD
Background—Ischemic preconditioning (IPC) is a mechanism protecting tissues from injury during ischemia and
reperfusion. Remote IPC (RIPC) can be elicited by applying brief periods of ischemia to tissues with ischemic tolerance,
thus protecting vital organs more susceptible to ischemic damage. Using a porcine model, we determined whether RIPC
of the limb is protective against brain injury caused by hypothermic circulatory arrest (HCA).
Methods and Results—Twelve piglets were randomized to control and RIPC groups. RIPC was induced in advance of
cardiopulmonary bypass by 4 cycles of 5 minutes of ischemia of the hind limb. All animals underwent cardiopulmonary
bypass followed by 60 minutes of HCA at 18°C. Brain metabolism and electroencephalographic activity were monitored
for 8 hours after HCA. Assessment of neurological status was performed for a week postoperatively. Finally, brain tissue
was harvested for histopathological analysis.
Study groups were balanced for baseline and intraoperative parameters. Brain lactate concentration was significantly
lower (P0.0001, ANOVA) and recovery of electroencephalographic activity faster (P0.05, ANOVA) in the RIPC
group. RIPC had a beneficial effect on neurological function during the 7-day follow-up (behavioral score; P0.0001
versus control, ANOVA). Histopathological analysis demonstrated a significant reduction in cerebral injury in RIPC
animals (injury score; mean [interquartile range]: control 5.8 [3.8 to 7.5] versus RIPC 1.5 [0.5 to 2.5], P0.001, t test).
Conclusions—These data demonstrate that RIPC protects the brain against HCA-induced injury, resulting in accelerated
recovery of neurological function. RIPC might be neuroprotective in patients undergoing surgery with HCA and
improve long-term outcomes. Clinical trials to test this hypothesis are warranted. (Circulation. 2011;123:714-721.)
Key Words: cardiac surgery  cerebral ischemia  cardiopulmonary bypass  reperfusion injury
 ischemic preconditioning
In the repair of complex congenital heart defects or insurgery of the aortic arch, normal circulation may be
temporarily halted to ensure a clean, bloodless operation
field. The brain is the organ most vulnerable to ischemic
injury during this period of hypothermic circulatory arrest
(HCA), and the mortality and morbidity of these procedures
today consists mostly of neurological complications.1,2 The
focus in recent years has shifted from reducing mortality to
alleviating long-term functional disability, a major determi-
nant of which is neurocognitive performance.
Editorial see p 709
Clinical Perspective on p 721
Preconditioning, a plausible neuroprotective strategy, de-
scribes a concept whereby brief exposure to a harmful
stimulus like ischemia, in a dose below the threshold for
tissue injury, provides robust protection against or tolerance
to the injurious effects of a subsequent more severe insult.3 In
vitro studies have confirmed that hypoxic preconditioning
protects cortical neurons from glutamate toxicity.4 In an
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experimental rat model, hippocampal CA1 cell counts re-
vealed significant neuronal sparing in preconditioned animals
observed 6 months after reperfusion with global cerebral
ischemia.5 The cerebral diffusion lesions and infarct volumes
following a human stroke have also been shown to be reduced
if a patient has a history of previous transient ischemic
attacks, thus eliciting a theory of a “natural” preconditioning
effect.6
As it is not always possible to mimic the exact ischemic
insult before the actual intervention, the introduction of
remote preconditioning has been eagerly received.7 In this
process, the preconditioning stimulus is applied to nontarget
tissue, most commonly to a skeletal muscle in a limb, and the
signal is thought to spread systemically by a mechanism that
includes activation of the autonomic nervous system and
as-yet unidentified humoral mediators. In remote ischemic
preconditioning (RIPC), intermittent ischemia is induced in
the limb most commonly by use of a blood pressure cuff or a
tourniquet, in cycles varying in time and repetitions.
We hypothesized that RIPC would improve brain protec-
tion in association with deep HCA. We tested this hypothesis
in a chronic porcine model, allowing us to mimic the devices
and procedures of human surgery very closely yet giving us the
opportunity to explore both acute and chronic parameters and,
most importantly, neurological recovery and brain histology
after ischemic changes.
Materials and Methods
Animals and Study Design
Twelve Yorkshire piglets of a native stock (25 to 30 kg) were
randomized using sealed envelopes to RIPC group (n6) and control
group (n6). Investigators performing experimental protocols
and/or postoperative assessment were blinded to group allocation.
All animals received humane care in accordance with the Principles
of Laboratory Animal Care formulated by the National Society for
Medical Research and the Guide for the Care and Use of Laboratory
Animals (http://www.nap.edu/catalog/5140.html). The study was
approved by the Research Animal Care and Use Committee of the
University of Oulu.
Induction of RIPC
RIPC was induced in advance of cardiopulmonary bypass (CPB) by
inflating a 9-cm-wide blood pressure cuff placed around the upper
part of a hindlimb. The cuff was inflated to 200 mm Hg for 5 minutes
(hindlimb ischemia) followed by a 5-minute deflation (reperfusion),
and the RIPC stimulus consisted of 4 inflation-deflation cycles (total
duration 40 minutes). Interruption of blood supply to the limb was
confirmed by vascular Doppler ultrasound. In animals randomized to
the control group, the blood pressure cuff was placed in the upper
part of the hindlimb, but was inflated to a pressure of 20 mm Hg, and
thus did not result in limb ischemia (sham RIPC). Four 5-minute
inflations and deflations were applied, as with the RIPC group.
Operative Protocol
Anesthesia
Animals were sedated with intramuscular ketamine hydrochloride
(350 mg) and midazolam (45 mg), and a peripheral catheter was
inserted into a vein of the right ear for administration of drugs and to
maintain fluid balance with Ringer acetate solution. Using thiopental
for further sedation as required, the piglets were intubated with a
6.5-mm cuffed endotracheal tube and ventilated with 50% oxygen
and a rate of 12 to 15 breaths per minute to achieve an end-tidal
carbon dioxide concentration in the expired air (EtCO2) of 4.5% to
5.0%. After induction with fentanyl (50 g/kg), anesthesia was
maintained by a continuous infusion of fentanyl (25 g  kg1  h1),
midazolam (0.25 mg  kg1  h1) and pancuronium (0.2
mg  kg1  h1), as well as inhalation anesthesia of 0.5% isoflurane
throughout the entire experiment, excluding the period of HCA.
Cefuroxime (1.5 g) was administered intravenously at induction of
anesthesia. ECG monitoring was carried out throughout the
entire operation.
Hemodynamic Monitoring
An arterial line for pressure monitoring and blood sampling was
placed on the left femoral artery. A pulmonary artery thermodilution
catheter (CritiCath, 7 Fr, Ohmeda GmbH & Co, Erlangen, Germany)
was introduced through the left femoral vein for measurement of
pulmonary pressure, pulmonary capillary wedge pressure, central
venous pressure, cardiac output, and temperature, as well as for
blood sampling. A 10 Fr catheter was placed in the urinary bladder
to monitor urine output. A right anterolateral thoracotomy was
performed in the fourth intercostal space to expose the right atrium
for CPB cannulation. The right internal thoracic artery and vein were
ligated and cut, and the pericardium was opened. After systemic
heparinization (500 IU/kg), the ascending aorta was cannulated with
a 16 Fr arterial cannula, and the right atrial appendage was
cannulated with a single 24 Fr atrial cannula. A 12 Fr intracardiac
sump cannula was positioned into the apex of the heart for decom-
pression during CPB.
Cranial Procedures
Three 5-mm windows were drilled over the parietal cortex. A
temperature probe (Thermocouple Temperature Catheter-Micro-
Probe, Ref C8.B, GMS, Kiel, Germany) was inserted in the first
window to monitor intracerebral temperature throughout the exper-
iment. A pressure-monitoring catheter (Codman Micro-Sensor ICP
Transducer, Codman ICP Express Monitor, Codman & Shurtleff Inc,
Raynham, MA) was placed into the cerebral tissue through the
second window for intracranial pressure measurements. Finally, a
microdialysis catheter (CMA 70, CMA/Microdialysis, Stockholm,
Sweden) was placed into the brain cortex (through the third window)
to a depth of 15 mm below the dura mater. The catheter was
connected to a 2.5-mL syringe placed into a microinfusion pump
(CMA 106, CMA/Microdialysis) and perfused with Ringer acetate
solution at a rate of 0.3 L/min (Perfusion Fluid CNS,
CMA/Microdialysis).
CPB and HCA
After baseline recordings of the RIPC or sham-RIPC protocol, a
membrane oxygenator (D905 Eos, Dideco, Mirandola, Italy) was
primed with 1 L of Ringer acetate solution and heparin (5000 IU).
Fresh whole blood from a donor pig, drawn on the operative day, was
transfused into the prime as required to maintain the hematocrit of all
animals above 25% after the operation (50 mL/kg). Nonpulsatile
CPB was initiated at a flow rate of 90 to 110 mL  kg1  min1, and
the flow was adjusted to maintain an arterial pressure of 50 to
70 mm Hg.
A 30-minute cooling period was carried out to attain a brain
temperature of 18°C. Cooling was managed according to the pH-stat
method of CPB for 25 minutes. The hypercarbia related to the
pH-stat strategy causes cerebral vasodilatation, resulting in improved
cooling and cerebral tissue oxygenation before the critical ischemic
period. Five minutes in advance of HCA, the pH strategy was
switched to -stat principles to normalize the biochemical status. A
heat exchanger was used for core cooling.
After 30 minutes of cooling, a 60-minute period of HCA at 18°C
was initiated and potassium chloride (40 mmol) was injected toward
the heart via CPB arterial cannula. Cardiac cooling with topical ice
slush was maintained throughout HCA. The intracerebral tempera-
tures were controlled and maintained at 18°C with ice packs placed
over the head.
At the beginning of rewarming, furosemide (40 mg), methylpred-
nisolone (80 mg), mannitol (150 g), calcium bioglyconate
(2.25 mmol Ca2) and lidocaine (40 mg) were administered into the
pump. During 45 minutes of rewarming, the piglets were warmed to
35°C with a 100 mL  kg1  min1 flow rate, so that the warming
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gradient was 10°C at all times. During rewarming, the pH was
managed according to the -stat principles. The heart was defibril-
lated if necessary at 27 to 30°C. The sump cannula was removed
after 30 minutes of rewarming. Sufficient ventilation was restored 10
minutes before weaning from CPB, which itself occurred at 45
minutes after the start of rewarming. Throughout rewarming and
after weaning from CPB, animal temperature was regulated using
heat exchange mattresses, heating lamps, paracetamol infusions (1 to
2g intravenously), and ice packs as required.
Postoperative Management
Noradrenalin was used postoperatively as required to maintain mean
arterial pressure over 60 mm Hg. Animals were extubated 8 hours
after the start of rewarming and were moved to a recovery room.
Each animal was electively euthanized on the seventh postoperative
day. Immediately after intravenous injection of pentobarbital (60
mg/kg) and heparin (500 IU/kg), the thoracic cavity was opened and
the descending thoracic aorta was clamped. Ringer solution (1 L)
was administered through the ascending thoracic aorta to the upper
body, and blood was suctioned from the superior vena cava until the
perfusate was clear of blood. Then, 10% formalin solution (1 L/15
minutes) was infused through the brain in the same manner to
accomplish perfusion fixation. Immediately thereafter, the entire
brain was harvested, weighed, and immersed in 10% neutral forma-
lin. No other tissue (including tissue from the heart, kidney and limb)
was harvested.
Sample Collection and Biochemical Data
Sample collection from microdialysis catheters was performed at set
time points intraoperatively (baseline, 30 minutes cooling, 30 min-
utes HCA, 60 minutes HCA, 30 minutes rewarm, 1 hour rewarm, 1
hour 30 minutes rewarm, 2 hours rewarm, 2 hours 30 minutes
rewarm, 3 hours rewarm, 4 hours rewarm, 5 hours rewarm, 6 hours
Table 1. Experimental and Metabolic Data
After the Start of Rewarming
Baseline End of Cooling 30 minutes 2 hours 4 hours 8 hours Pg Pt  g
pH 0.050 0.14
RIPC 7.57 (7.55–7.60) 7.26 (7.25–7.29) 7.44 (7.42–7.46) 7.42 (7.36–7.50) 7.56 (7.46–7.61)* 7.61 (7.58–7.63)*
Control 7.49 (7.41–7.56) 7.20 (7.15–7.32) 7.47 (7.40–7.56) 7.37 (7.27–7.42) 7.42 (7.38–7.51) 7.46 (7.42–7.54)
PaCO2, kPa 0.11 0.59
RIPC 4.18 (3.82–4.51) 9.36 (8.59–9.63) 4.20 (3.56–4.32) 4.97 (4.38–5.69) 4.4 (3.9–4.9) 3.9 (3.8–4.5)*
Control 4.53 (3.68–5.40) 11.2 (7.16–12.9) 4.23 (3.31–5.00) 5.55 (5.02–6.26) 5.4 (4.2–6.3) 5.1 (4.3–5.5)
PaO2, kPa 0.36 0.29
RIPC 33.0 (29.2–36.8) 106 (106–106) 67.7 (59.1–75.6) 31.2 (26.8–33.7) 31.3 (27.9–32.3) 28.1 (26.5–31.4)
Control 32.4 (30.1–35.7) 106 (106–106) 68.8 (66.6–73.9) 26.6 (20.5–32.5) 29.8 (24.2–39.8) 31.2 (24.8–39.7)
SvO2, % 0.47 0.33
RIPC 77.5 (74.5–85.3) 100 (100–100) 74.5 (70.3–82.8)* 78.0 (73.0–82.0) 77.0 (74.8–79.3) 73.5 (61.0–79.3)
Control 80.0 (77.8–81.3) 100 (100–100) 89.0 (81.3–90.5) 78.5 (72.8–84.0) 73.5 (60.8–80.3) 75.5 (63.5–80.6)
Heart rate, bpm 0.64 0.78
RIPC 102 (112–127) . . . 132 (88–164) 108 (98–130) 124 (111–135) 123 (119–144)
Control 115 (105–124) . . . 128 (72–144) 110 (77–131) 127 (105–151) 121 (103–151)
Mean arterial
pressure, mm Hg
0.83 0.41
RIPC 84 (75–87) 65 (62–67) 60 (53–64) 103 (88–112) 104 (96–108) 97 (89–105)
Control 73 (70–104) 64 (54–72) 60 (59–67) 95 (79–97) 95 (82–105) 93 (89–113)
Pulmonary artery
pressure, mm Hg
0.78/0.78 0.24/0.32
RIPC 18 (16–20)/12 (9–12) . . . . . . 29 (26–34)/19 (17–22) 26 (21–30)/17 (16–22) 27 (22–31)/15 (15–19)*
Control 17 (15–19)/11 (9–14) . . . . . . 30 (28–32)/20 (18–21) 30 (25–34)/21 (17–23) 26 (23–26)/13 (12–14)
Hematocrit, % 0.72 0.57
RIPC 22.0 (18.8–25.3) 24.5 (20.8–26.0) 24.0 (21.0–28.5) 29.0 (25.0–30.1) 30.0 (27.3–30.3) 28.8 (27.9–30.0)
Control 22.0 (18.4–23.3) 24.0 (20.8–25.8) 24.3 (20.8–24.9) 31.0 (24.5–32.9) 30.5 (29.0–34.8) 28.0 (27.5–33.3)
Intracerebral
temperature, °C
0.75 0.26
RIPC 37.1 (36.7–37.7) 17.0 (16.8–17.3) 31.5 (30.5–33.3) 34.3 (32.2–35.0) 36.0 (34.6–37.2) 37.4 (36.9–38.1)
Control 37.7 (37.2–38.3) 16.3 (16.0–17.3) 33.2 (30.8–34.6) 33.4 (32.8–34.2) 35.8 (35.5–37.0) 38.0 (37.0–38.4)
Rectal
temperature, °C
0.49 0.83
RIPC 37.6 (37.1–38.2) 16.6 (14.3–17.3) 29.2 (26.5–32.0) 34.1 (32.6–35.0) 36.7 (34.5–37.7) 37.9 (37.2–38.5)
Control 38.0 (37.8–38.2) 15.3 (14.1–17.5) 27.2 (25.6–30.4) 33.8 (33.0–34.1) 36.0 (35.7–36.3) 37.6 (37.2–38.1)
Blood
temperature, °C
0.70 0.89
RIPC 37.5 (37.1–38.1) 9.6 (7.7–17.7) 36.9 (34.8–37.7) 34.2 (32.8–35.1) 36.8 (34.6–37.6) 37.9 (37.3–38.7)
Control 37.9 (37.6–38.2) 10.3 (8.0–14.1) 35.0 (33.1–36.4) 33.9 (33.3–34.5) 36.4 (35.9–37.2) 38.1 (37.5–38.4)
RIPC n6, Control n6. Values are shown as medians and 25th and 75th percentiles. PaCO2 indicates arterial CO2 partial pressure; SvO2, mixed venous oxygen
saturation.
*P0.05 at single time point.
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rewarm, 7 hours rewarm, 8 hours rewarm). The concentrations of
cerebral tissue glucose, lactate, pyruvate, glutamate, and glycerol
were measured immediately after collection with a microdialysis
analyzer (CMA 600, CMA/Microdialysis), using established enzy-
matic methods. Arterial blood gases, pH, electrolytes, serum ionized
calcium, glucose and hemoglobin levels (i-STAT Analyzer, i-STAT
Corp, East Windsor, NJ) were measured at baseline, at the end of
cooling (immediately before institution of HCA), as well as 30
minutes, 2 hours, 4 hours, and 8 hours after the start of rewarming.
At these time points, samples for full blood cell count, cardiac
troponin I, creatine kinase isoenzyme MB, and plasma analysis were
collected. In order to control arterial CO2 gas tension precisely,
sampling was performed at least every 15 minutes during CPB.
Protein Biomarkers for Brain Damage
All samples were analyzed, with the analyst being blinded to all
other data. Serum neurofilament heavy chain (NfH) levels were
measured using an in-house developed enzyme-linked immunosor-
bent assay (ELISA). Adhering to a previously proposed nomencla-
ture, the soluble fraction of NfH measured is indicated with the
capture of antibody in the superscript (NfHSMI35). We concentrated
on NfHSMI35 instead of the neurofilament light chain because of its
relative resistance to proteolysis, an important feature for reliable
measurement in body fluids.8 Serum S100-B levels were measured
using a modified in-house developed ELISA, as described
previously.9
Multimodal Neurophysiological Monitoring
Cortical electric activity was registered by four 5-mm stainless-steel
screw electrodes implanted into the skull over the parietal and frontal
areas using a digital electroencephalography (EEG) recorder (Ner-
vus, Reykjavik, Iceland) and amplifier (Magnus EEG 32/8, Reykja-
vik, Iceland). Sampling frequency was 256 Hz and bandwidth was
Figure 1. Cardiac index. Mean1 SE. Figure 2. Cardiac troponin I. Mean1 SE.
Table 2. Experimental and Metabolic Data
After the Start of Rewarming
Baseline End of Cooling 30 minutes 2 hours 4 hours 8 hours Pg Pt  g
Central venous pressure, mm Hg 0.31 0.79
RIPC 6 (3–6) 3 (1–6) 2 (1–4) 9 (7–9) 9 (8–9) 9 (8–9)
Control 5 (4–5) 2 (1–3) 2 (2–2) 9 (7–11) 8 (7–9) 7 (5–10)
Intracranial pressure, mm Hg 0.18 0.86
RIPC 8 (5–13) 9 (8–15) 9 (6–11) 14 (10–17) 12 (10–19)* 15 (12–19)†
Control 3 (1–8) 8 (4–10) 5 (4–8) 9 (8–13) 9 (8–10) 11 (9–12)
Cerebral perfusion pressure, mm Hg 0.55 0.66
RIPC 71 (56–79) 57 (47–59) 50 (47–53)* 80 (67–92) 91 (70–92) 81 (70–86)
Control 76 (62–94) 62 (43–69) 55 (54–56) 80 (71–84) 78 (67–90) 79 (76–92)
Oxygen consumption, mL  min1  m2) 0.037 0.37
RIPC 7.4 (6.5–8.1) 0.0 (0.0–0.1) 5.5 (4.2–7.2)* 7.4 (6.3–8.8) 8.7 (6.7–10.3) 10.8 (7.9–14.3)
Control 5.4 (4.5–6.8) 0.0 (0.0–0.2) 2.7 (2.3–3.9) 5.1 (3.3–8.6) 7.7 (4.7–8.7) 7.4 (3.1–10.6)
Oxygen delivery, mL  min1  m2) 0.69 0.72
RIPC 4.1 (3.9–5.3) 3.2 (2.8–3.8) 3.0 (2.0–4.1) 4.2 (3.6–5.4) 5.7 (5.5–6.8) 5.7 (5.5–6.2)
Control 3.9 (3.3–4.6) 3.1 (2.5–4.3) 3.0 (2.7–4.0) 3.9 (3.5–4.5) 6.0 (5.2–6.2) 5.5 (5.0–6.0)
Oxygen extraction, mL/dL 0.71 0.25
RIPC 2.0 (1.7–2.4) 0.0 (0.0–0.0) 2.9 (1.9–3.8)* 2.7 (2.5–3.4) 3.0 (2.9–3.3) 3.4 (2.6–5.0)
Control 2.0 (1.–2.1) 0.0 (0.0–0.1) 1.3 (1.1–1.9) 2.7 (1.7–3.9) 3.8 (2.6–6.0) 3.5 (2.4–4.8)
Venous glucose, mmol/L 0.90 0.013
RIPC 4.6 (3.9–4.9) 4.1 (3.8–4.6) 10.8 (9.4–11.5) 5.9 (4.9–6.7) 5.2 (4.7–5.7) 5.3 (4.6–5.5)
Control 5.2 (3.2–7.4) 4.9 (3.2–5.8) 8.3 (7.1–11.4) 5.9 (5.0–7.4) 4.7 (3.8–5.4) 4.2 (4.0–5.5)
Osmolality, mmol/kg 0.82 0.67
RIPC 274 (269–277) 276 (272–279) 278 (273–280) 277 (272–279) 275 (274–278) 275 (275–279)
Control 274 (272–280) 278 (276–283) 273 (272–284) 275 (272–281) 273 (269–278) 274 (269–282)
RIPC n6, Control n6. Values are shown as medians and 25th and 75th percentiles.
*P0.05 at single time point; †P 0.05 and 0.06.
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0.03 to 100 Hz. All EEG recordings were referenced to a frontal
screw electrode that, together with a ground screw electrode, was
implanted over the frontal sinuses. A 10-minute baseline EEG
recording was performed in advance of the cooling period. EEG
recording was reinstituted after HCA and continued until extubation.
Artifact periods were excluded from each 5-minute sample. The
EEG energy recovery was evaluated by an algorithm based on a
nonlinear energy operator.
Regional cerebral blood oxygen saturation was measured nonin-
vasively by near-infrared spectroscopy (INVOS Cerebral Oxymeter,
Somanetics, Troy, MI). Two adhesive near-infrared light sensors
(SomaSensors, Somanetics, Troy, MI) were positioned over the
frontal cortex (one on each side to measure right and left hemisphere
regional cerebral blood oxygen saturation), and regional cerebral
blood oxygen saturation monitoring was performed continuously
from CPB induction up to extubation and recovery (total of 24
hours).
Behavioral Evaluation
Postoperatively, all animals were evaluated daily by an experienced
observer using a species-specific quantitative behavioral score. The
quantified assessments of mental status (0comatose, 1stuporous,
2depressed, and 3normal), appetite (0refuses liquids, 1re-
fuses solids, 2decreased, and 3normal), and motor function
(0unable to stand, 1unable to walk, 2unsteady gait, and
3normal) were summed to obtain a final score, with a maximum
score of 9 reflecting apparently normal neurological function and
with lower values indicating substantial brain damage.
Histopathological Analysis
During autopsy, the brain was excised immediately and the hemi-
spheres were separated. One half was immersed in 10% neutral
formalin and allowed to fix for 2 weeks en bloc. Coronal samples
3-mm thick were sliced from the frontal lobe, thalamus (including
the adjacent cortex), and hippocampus (including the adjacent brain
stem and temporal cortex), and sagittal samples were sliced from the
posterior brain stem (medulla oblongata and pons) and cerebellum.
The pieces were fixed in fresh formalin for another week. After
fixation, the samples were processed as follows: rinsing in water for
20 minutes and immersion in 70% ethanol for 2 hours, in 94%
ethanol for 4 hours, and in absolute ethanol for 9 hours. Thereafter,
the pieces were kept 1 hour in an absolute ethanol-xylene mixture, 4
hours in xylene, and embedded in warm paraffin wax for 6 hours.
The samples were sectioned at 6 m and stained with hematoxylin-
eosin. The sections of the brain samples from each animal were
screened by a single experienced senior pathologist unaware of the
experimental design and the identity and fate of individual animals.
Each section was carefully investigated for the presence or absence
of any ischemic or other damage.
Sections of brain specimens (cortex, thalamus, hippocampus,
posterior brain stem, cerebellum) from each animal were screened by
a single blinded neuropathologist. The signs of injury were scored as
follows: 1 (slight edema, dark or eosinophilic neurons, or cerebellar
Purkinje cells), 2 (moderate edema, at least 2 hemorrhagic foci in the
section), and 3 (severe edema, several hemorrhagic foci, infarct foci
[local necrosis]). The total regional score was the sum of the scores
in each specific brain area (cortex, thalamus, hippocampus, posterior
brain stem, and cerebellum). A total histopathological score was
calculated by summing all regional scores to allow semiquantitative
comparison between the animals.
Statistical Analysis
Statistical analysis was performed using SPSS (SPSS, version 12.0,
SPSS Inc, Chicago, IL) and SAS (version 9.1.3, SAS Institute Inc.,
Cary, NC) statistical software. Continuous and ordinal variables are
expressed as the median and 25th and 75th percentiles in the tables.
SAS procedure Mixed was used for these repeated measurements.
Because the measurement intervals were uneven, spatial exponential
covariance structure was chosen in repeated statement, assuming that
the further apart the measurements are in time, the weaker the
correlation between them. Complete independence was assumed
across animals (by random statement). Reported P values are as
follows: P between groups (Pg) indicates a level of difference
between the groups, P time  group (Pt  g) indicates behavior be-
tween the groups over time. Student t test, 2-way ANOVA, or
Mann-Whitney U test was used as appropriate to assess the distri-
bution of variables between the study groups. Two-tailed signifi-
cance levels are reported. P0.05 was considered statistically
significant. In the figures, mean and error bar of 1 SE was used.
Results
Comparability of the Study Groups
The mean weight of the pigs was 29.6 kg in the RIPC group
and 26.8 kg in the control group (P0.076). The amount of
Figure 3. Creatine kinase isoenzyme MB. Mean1 SE.
Figure 4. Cerebral concentration of lactate. Mean1 SE.
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transfused blood was 52.2 mL/kg (48.4 to 54.8) in the RIPC
group and 50.9 mL/kg (44.9 to 53.7) in the control group
(P0.66). The 2 study groups did not differ in duration of
cooling (P0.140) or rewarming (P1.0), number of defi-
brillations (P0.857), or the need for inotropes after the
operation (P0.195). The temperatures during HCA were
similar in both groups both relative to the cerebral tempera-
ture (Pg0.67) and the rectal temperature (Pg0.13). Exper-
imental and metabolic data are summarized in Tables 1 and 2.
No clinically significant differences were observed between
the groups.
Cardiac Function
After weaning from CPB, the animals in the RIPC group
demonstrated a tendency for a better cardiac index (Figure 1).
Overall, the difference between group pattern of this variable
was significant (P2-way ANOVA0.001), with the cardiac index
showing higher mean levels at 4 and 8 hours after the start of
rewarming. The levels of cardiac enzymes also differed
between the groups, reflected in the increased release of
Troponin I (P2-way ANOVA0.01) and creatine kinase isoen-
zyme MB (P2-way ANOVA0.002) in the control group with
mean differences emerging at 2, 4, and 8 hours after the start
of rewarming (Figure 2 and 3).
Intracranial Measurements
Microdialysis Data
We did not observe any differences in the concentrations of
cerebral glucose (Pg0.24), glutamate (Pg0.40), pyruvate
(Pg0.16) or glycerol (Pg0.16). However, the concentra-
tion of cerebral lactate tended to be higher in the control
group (P2-way ANOVA0.0001) and also demonstrated more
variance than in the RIPC-group (Figure 4). In spite of this,
no differences between the groups were displayed in the
glucose-lactate ratio (Pg0.31) or the lactate-pyruvate ratio
(Pg0.73).
EEG Monitoring
The EEG activity returned to baseline levels during the 8-hour
follow-up period in all animals in both groups. However, the
pattern of EEG recovery in the RIPC group seemed to be faster
than that of the control group (P2-way ANOVA 0.01, Figure 5).
Intracranial Pressure
Intracranial pressure tended to be slightly higher in the RIPC
group toward the end of the follow-up period (Table 2),
however it remained within normal range, and no overall
difference between the groups were detected (Pg0.18).
Neurological Markers
The concentration of S100-B behaved rather similarly in both
groups, beginning to rise as rewarming started, peaking at 2
hours after HCA, and falling back to almost baseline levels at
the end of the 8-hour follow-up (Figure 6). However, peak
concentrations seemed to be higher in the control group
(P2-way ANOVA0.0014).
The level of NfH was observed to be similar in both groups
at baseline, but after that the concentration was persistently
higher in the control group (P2-way ANOVA0.0008). In both
groups, peak levels were observed right at the beginning of
rewarming after HCA (Figure 7).
Behavioral Recovery
All 12 animals survived the experiment and lived for the
entire follow-up period. All but 1 animal in the control group
Figure 5. EEG activity. Mean1 SE.
Figure 6. Concentration of S100-B. Mean1 SE.
Figure 7. Concentration of NfH. Mean1 SE.
Figure 8. Behavioral score in the postoperative period. Mean1 SE.
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recovered fully in terms of their neurological status, scoring a
full 9 points by the seventh postoperative day. The animals of
the RIPC group recovered faster (P2-way ANOVA0.0001), a
difference most notable during the first 2 postoperative days
(Figure 8). The cumulative behavioral recovery score was 54
(52 to 56) in the RIPC group and 50 (44 to 52) in the control
group (P0.078).
Histological Injury
The total histopathological score of ischemic injury was 1.5
(0.5 to 2.5) in the RIPC group and 5.8 (3.8 to 7.5) in the
control group (P0.001). The most defining difference be-
tween the groups was observed in the cortex and hippocam-
pus (Table 3). Hemorrhages and neuronal damage were
observed only in the control group, and the rate of edema was
clearly higher compared to the RIPC group (P0.002).
Discussion
The present study demonstrates that RIPC of the limb
protects the brain against ischemia–reperfusion injury in a
porcine model of HCA. In this surviving animal trial we
found that the brain lactate concentration sequentially mea-
sured after surgery was lower, and the recovery of EEG
activity was faster in the RIPC group compared to the control
group. RIPC had a beneficial effect on neurological function
during the 7-day follow-up period in terms of behavioral
score. Histopathological analysis demonstrated a significant
reduction in cerebral injury in RIPC animals compared to
controls. Study groups were balanced for baseline and intra-
operative parameters.
The overall mortality for complex congenital heart surgery
has come a long way. Attention has been directed to neuro-
logical dysfunction and developmental sequelae after neona-
tal cardiac surgery with its support techniques and deep HCA.
Some surgical and CPB strategies have been developed to
offer cerebral protection at the time of aortic arch reconstruc-
tion, such as the pH-stat strategy,10 high hematocrit,11 con-
tinuous low-flow CPB,12 and selective regional perfusion.13
In experimental myocardial infarction models, RIPC has
been shown to reduce infarction size and improve myocardial
protection.14,15,16 RIPC has also been shown to be protective
against ischemia–reperfusion damage in the kidney,17 liver,18
skeletal muscle,19 pancreas,20 small intestine,21 and brain in
association with stroke.22 In humans, RIPC has been shown to
protect against experimental endothelial dysfunction,16,23 to
modify circulating neutrophil gene expression,24 to reduce
myocardial damage, to improve lung function, and to de-
crease inflammation markers in children undergoing cardiac
surgery.25 Its potential has been strengthened by our recent
findings in an acute porcine model of HCA, where RIPC
provided a faster recovery of cortical neuronal activity,
protection against potential cerebral oxygen radical–mediated
ischemia damage, and a decrease in late-phase lactate and
pyruvate burst in the brain, mitigating possible damage from
an anaerobic metabolism phase.26
The present study demonstrates that the neuroprotective
effect after a series of blood pressure cuff inflations before
HCA in a surviving-animal model was associated with a
significant reduction in some important markers of neurolog-
ical injury, accelerating neurological recovery and mitigating
histopathological findings. RIPC might be neuroprotective in
patients undergoing surgery with HCA and improve long-
term outcomes. If intermittent limb occlusions are shown
consistently to reduce neurological injury during complex
cardiac surgery with HCA, clinical implications can be
very important. The intervention is practical and noninva-
sive, and clinical trials to further investigate its applica-
tions are warranted.
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CLINICAL PERSPECTIVE
In the repair of complex congenital heart defects or in surgery of the aortic arch, normal circulation may be temporarily
halted to ensure a clean bloodless operation field. The brain is the organ most vulnerable to ischemic injury during this
period of hypothermic circulatory arrest (HCA), and the mortality and morbidity of these procedures today consists largely
of neurological complications. Ischemic preconditioning, a plausible neuroprotective strategy, describes a concept whereby
brief exposure to ischemia, in a dose below the threshold for tissue injury, provides robust protection against the injurious
effects of a subsequent more severe insult. In remote ischemic preconditioning, intermittent ischemia is induced in a
nontarget tissue such as the limb, and the signal is thought to spread systemically by a mechanism that includes activation
of the autonomic nervous system and as yet unidentified humoral mediators. Our study demonstrates that the
neuroprotective effect after a series of blood pressure cuff inflations of the hind leg before HCA in a surviving porcine
model was associated with a significant reduction in some important markers of neurological injury, accelerated
neurological recovery and mitigated cerebral histopathological findings. Remote ischemic preconditioning might be
neuroprotective in patients undergoing surgery with HCA and improve long-term outcomes. If intermittent limb occlusions
are shown consistently to reduce neurological injury during complex cardiac surgery with HCA, clinical implications can
be very important. The intervention is practical, cost effective, and noninvasive. Clinical trials to further investigate its
applications are warranted.
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